» Articles » PMID: 25392207

The Nature of the N-terminal Amino Acid Residue of HIV-1 RNase H is Critical for the Stability of Reverse Transcriptase in Viral Particles

Overview
Journal J Virol
Date 2014 Nov 14
PMID 25392207
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) is synthesized and packaged into the virion as a part of the GagPol polyprotein. Mature RT is released by the action of viral protease. However, unlike other viral proteins, RT is subject to an internal cleavage event leading to the formation of two subunits in the virion: a p66 subunit and a p51 subunit that lacks the RNase H domain. We have previously identified RNase H to be an HIV-1 protein that has the potential to be a substrate for the N-end rule pathway, which is an ubiquitin-dependent proteolytic system in which the identity of the N-terminal amino acid determines the half-life of a protein. Here we examined the importance of the N-terminal amino acid residue of RNase H in the early life cycle of HIV-1. We show that changing this residue to an amino acid structurally different from the conserved residue leads to the degradation of RT and, in some cases, integrase in the virus particle and this abolishes infectivity. Using intravirion complementation and in vitro protease cleavage assays, we show that degradation of RT in RNase H N-terminal mutants occurs in the absence of active viral protease in the virion. Our results also indicate the importance of the RNase H N-terminal residue in the dimerization of RT subunits.

Importance: HIV-1 proteins are initially made as part of a polyprotein that is cleaved by the viral protease into the proteins that form the virus particle. We were interested in one particular protein, RNase H, that is cleaved from reverse transcriptase. In particular, we found that the first amino acid of RNase H never varied in over 1,850 isolates of HIV-1 that we compared. When we changed the first amino acid, we found that the reverse transcriptase in the virus was degraded. While other studies have implied that the viral protease can degrade mutant RT proteins, we show here that this may not be the case for our mutants. Our results suggest that the presence of active viral protease is not required for the degradation of RT in RNase H N-terminal mutants, suggesting a role for a cellular protease in this process.

Citing Articles

Isolation of amaranthin synthetase from Chenopodium quinoa and construction of an amaranthin production system using suspension-cultured tobacco BY-2 cells.

Imamura T, Isozumi N, Higashimura Y, Miyazato A, Mizukoshi H, Ohki S Plant Biotechnol J. 2018; 17(5):969-981.

PMID: 30451369 PMC: 6587806. DOI: 10.1111/pbi.13032.


Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review.

Tarasova O, Poroikov V, Veselovsky A Molecules. 2018; 23(5).

PMID: 29883406 PMC: 6100360. DOI: 10.3390/molecules23051233.


Structural integrity of the ribonuclease H domain in HIV-1 reverse transcriptase.

Slack R, Spiriti J, Ahn J, Parniak M, Zuckerman D, Ishima R Proteins. 2015; 83(8):1526-38.

PMID: 26061827 PMC: 4509971. DOI: 10.1002/prot.24843.

References
1.
Somia N, Schmitt M, Vetter D, Van Antwerp D, Heinemann S, Verma I . LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death. Proc Natl Acad Sci U S A. 1999; 96(22):12667-72. PMC: 23041. DOI: 10.1073/pnas.96.22.12667. View

2.
Boso G, Tasaki T, Kwon Y, Somia N . The N-end rule and retroviral infection: no effect on integrase. Virol J. 2013; 10:233. PMC: 3716682. DOI: 10.1186/1743-422X-10-233. View

3.
Tachedjian G, Aronson H, De Los Santos M, Seehra J, McCoy J, Goff S . Role of residues in the tryptophan repeat motif for HIV-1 reverse transcriptase dimerization. J Mol Biol. 2003; 326(2):381-96. DOI: 10.1016/s0022-2836(02)01433-x. View

4.
Mulky A, Sarafianos S, Arnold E, Wu X, Kappes J . Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo. J Virol. 2004; 78(13):7089-96. PMC: 421671. DOI: 10.1128/JVI.78.13.7089-7096.2004. View

5.
Pettit S, Everitt L, Choudhury S, Dunn B, Kaplan A . Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism. J Virol. 2004; 78(16):8477-85. PMC: 479095. DOI: 10.1128/JVI.78.16.8477-8485.2004. View